Sobiak, J.; Jóźwiak, A.; Wziętek, H.; Zachwieja, J.; Ostalska-Nowicka, D.
The Application of Inosine 5′-Monophosphate Dehydrogenase Activity Determination in Peripheral Blood Mononuclear Cells for Monitoring Mycophenolate Mofetil Therapy in Children with Nephrotic Syndrome. Pharmaceuticals 2020, 13, 200.
https://doi.org/10.3390/ph13080200
AMA Style
Sobiak J, Jóźwiak A, Wziętek H, Zachwieja J, Ostalska-Nowicka D.
The Application of Inosine 5′-Monophosphate Dehydrogenase Activity Determination in Peripheral Blood Mononuclear Cells for Monitoring Mycophenolate Mofetil Therapy in Children with Nephrotic Syndrome. Pharmaceuticals. 2020; 13(8):200.
https://doi.org/10.3390/ph13080200
Chicago/Turabian Style
Sobiak, Joanna, Alicja Jóźwiak, Honorata Wziętek, Jacek Zachwieja, and Danuta Ostalska-Nowicka.
2020. "The Application of Inosine 5′-Monophosphate Dehydrogenase Activity Determination in Peripheral Blood Mononuclear Cells for Monitoring Mycophenolate Mofetil Therapy in Children with Nephrotic Syndrome" Pharmaceuticals 13, no. 8: 200.
https://doi.org/10.3390/ph13080200
APA Style
Sobiak, J., Jóźwiak, A., Wziętek, H., Zachwieja, J., & Ostalska-Nowicka, D.
(2020). The Application of Inosine 5′-Monophosphate Dehydrogenase Activity Determination in Peripheral Blood Mononuclear Cells for Monitoring Mycophenolate Mofetil Therapy in Children with Nephrotic Syndrome. Pharmaceuticals, 13(8), 200.
https://doi.org/10.3390/ph13080200
